Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • How to calculate...

    How to calculate Pharma Prices with GST: NPPA issues notification

    Written by Ruby Khatun Khatun Published On 2017-06-10T11:18:29+05:30  |  Updated On 10 Jun 2017 11:18 AM IST
    How to calculate Pharma Prices with GST: NPPA issues notification

    With the announcement of common taxation that is Goods and Services Taxes ( GST) on pharmaceutical products, National pharmaceutical pricing Authority ( NPPA), Department of Pharmaceuticals, has specified how the ceiling prices of scheduled drugs with be calculated in the Presence of GST.


    Through an office memorandum, the Authority stated that in its 46th meeting held on 08.6.2017 has decided to notify ceiling prices of scheduled formulations, exclusive of applicable GST rates, after the GST rates are notified by the Government, as detailed below:




    • In case of scheduled formulations, where presently excise duty is levied on MRP, the revised ceiling price exclusive of applicable GST rates would be calculated by applying a factor of 0.95905 to the existing notified ceiling price. The factor has been worked out as follows:













































    Computation of the Factor to arrive at the revised ceiling prices(Rs.)
    aCeiling Price fixed before 30.6.2017 ( Incl. Excise Duty)100.00
    bAdd, Local TaxesNAT on above (@ 5%)5.00
    cMRP (inclusive of all taxes)105.00
    dLess: Excise Duty of the 6% on 65% of MRP4.095
    eLess: Local taxesNAT as applicable5.00
    fRevised Ceiling Price to be re-notified (excluding GST)95.905
    FACTOR (f/a)0.95905


    • In case of scheduled formulations, which are exempted from excise duty, no multiplication factor would be applicable. The existing notified ceiling price would be the ceiling price exclusive of GST rates as applicable.

    • In case of non-scheduled formulations, paragraph 20 of the DPCO, 2013 needs to be followed irrespective of any change in the tax structure or tax rates. The companies will have no option but to absorb the net increase, if any, in the incidence of tax on implementation of GST within the permissible limit of 10% for increase of Maximum Retail Price compared to the MRP of preceding 12 months as prescribed under paragraph 20 of the DPCO, 2013.


    However, in case of savings due to lower rate of tax, the benefit may be passed on to the consumers as per the anti-profiteering clause in GST rules.


    The notice also stated that after the notification of GST rates by the Government, the ceiling price of scheduled formulations would be worked out and notified as explained above.

    ceiling pricesDepartment of PharmaceuticalsDPCODrug (Price Control) OrderGoods and Services TaxesGSTNational Pharmaceutical Pricing AuthorityNPPAScheduled formulations
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok